1. Home
  2. APGE vs CBT Comparison

APGE vs CBT Comparison

Compare APGE & CBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apogee Therapeutics Inc.

APGE

Apogee Therapeutics Inc.

HOLD

Current Price

$72.11

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Logo Cabot Corporation

CBT

Cabot Corporation

HOLD

Current Price

$69.98

Market Cap

3.8B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
APGE
CBT
Founded
2022
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
3.8B
IPO Year
2023
1994

Fundamental Metrics

Financial Performance
Metric
APGE
CBT
Price
$72.11
$69.98
Analyst Decision
Strong Buy
Hold
Analyst Count
11
3
Target Price
$102.40
$70.00
AVG Volume (30 Days)
799.5K
414.0K
Earning Date
01-01-0001
05-05-2026
Dividend Yield
N/A
2.43%
EPS Growth
N/A
N/A
EPS
N/A
1.37
Revenue
N/A
$3,713,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2.89
P/E Ratio
N/A
$54.15
Revenue Growth
N/A
N/A
52 Week Low
$26.20
$58.33
52 Week High
$84.56
$89.15

Technical Indicators

Market Signals
Indicator
APGE
CBT
Relative Strength Index (RSI) 55.03 35.69
Support Level $35.24 $65.48
Resistance Level $82.77 $78.03
Average True Range (ATR) 3.57 2.24
MACD 0.60 -0.67
Stochastic Oscillator 79.23 2.30

Price Performance

Historical Comparison
APGE
CBT

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

About CBT Cabot Corporation

Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into the following operating segments based on the product type; the Reinforcement Materials segment which generates maximum revenue provides reinforcing carbon products used in tires, and industrial products such as hoses, belts, extruded profiles, and molded goods; and the Performance Chemicals segment aggregates the specialty carbons, specialty compounds, fumed metal oxides, battery materials, inkjet colorants, and aerogel product lines. Geographically, the company derives maximum revenue from its customers in Europe, the Middle East, and Africa and the rest from the Americas and Asia Pacific region.

Share on Social Networks: